Abstract
Purpose
Previous studies have shown an association of sarcopenia with adverse short- and long-term outcomes in multiple gastrointestinal cancer types. We aimed to investigate the prognostic value of sarcopenia on the postoperative outcomes and survival rates of patients with colorectal cancer (CRC).
Methods
A systematic literature search was performed using the PubMed, Embase, Cochrane, Google Scholar, and Scopus databases. We included studies that compared postoperative outcomes or survival rates in sarcopenic and non-sarcopenic patients with CRC.
Results
A total of 44 observational studies, comprising 18,891 patients, were included. The pooled prevalence of sarcopenia was 37% (n = 7009). The pooled analysis revealed an association between sarcopenia and higher risk of total postoperative complications (23 studies, OR = 1.84; 95% CI 1.35–2.49), postoperative severe complications (OR = 1.72; 95% CI 1.10–2.68), postoperative mortality (OR = 3.21; 95% CI 2.01–5.11), postoperative infections (OR = 1.40; 95% CI 1.12–1.76), postoperative cardiopulmonary complications (OR = 2.92; 95% CI 1.96–4.37), and prolonged length of stay (MD = 0.77; 95% CI 0.44–1.11) after colorectal cancer surgery. However, anastomotic leakage showed comparable occurrence between sarcopenic and non-sarcopenic patients (OR = 0.99; 95% CI 0.72 to 1.36). Regarding survival outcomes, sarcopenic patients had significantly shorter overall survival (25 studies, HR = 1.83; 95% CI = 1.57–2.14), disease-free survival (HR = 1.55; 95% CI = 1.29–1.88), and cancer-specific survival (HR = 1.77; 95% CI 1.40–2.23) as compared with non-sarcopenic patients.
Conclusion
Among patients with colorectal cancer, sarcopenia is a strong predictor of increased postoperative complications and worse survival outcomes.
Similar content being viewed by others
Data availability
All data is available upon request.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
Sun G, Li Y, Peng Y, Lu D, Zhang F, Cui X, Zhang Q, Li Z (2018) Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis. Int J Color Dis 33:1419–1427
Okugawa Y, Toiyama Y, Hur K, Yamamoto A, Yin C, Ide S, Kitajima T, Fujikawa H, Yasuda H, Koike Y, Okita Y, Hiro J, Yoshiyama S, Araki T, Miki C, McMillan DC, Goel A, Kusunoki M (2019) Circulating miR-203 derived from metastatic tissues promotes myopenia in colorectal cancer patients. J Cachexia Sarcopenia Muscle 10:536–548
Aleixo GFP, Shachar SS, Nyrop KA, Muss HB, Malpica L, Williams GR (2020) Myosteatosis and prognosis in cancer: systematic review and meta-analysis. Crit Rev Oncol Hematol 145:102839
Simonsen C, de Heer P, Bjerre E, Suetta C, Hojman P, Pedersen B et al (2018) Sarcopenia and postoperative complication risk in gastrointestinal surgical oncology. Ann Surg 268:58–69
Lee CM, Kang J (2020) Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 11(5):1270–1282
Vergara-Fernandez O, Trejo-Avila M, Salgado-Nesme N (2020) Sarcopenia in patients with colorectal cancer: a comprehensive review. World Journal of Clinical Cases 8:1188–1202
Rosenberg I (1989) Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 50:1231–1233
Cruz-Jentoft A, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:601–601
Cespedes Feliciano E, Avrutin E, Caan B, Boroian A, Mourtzakis M (2018) Screening for low muscularity in colorectal cancer patients: a valid, clinic-friendly approach that predicts mortality. J Cachexia Sarcopenia Muscle 9:898–908
Ryan A, Power D, Daly L, Cushen S, Ní Bhuachalla Ē, Prado C (2016) Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later. Proc Nutr Soc 75:199–211
Liu P, Hao Q, Hai S, Wang H, Cao L, Dong B (2017) Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: a systematic review and meta-analysis. Maturitas 103:16–22
Hua H, Xu X, Tang Y, Ren Z, Xu Q, Chen L (2019) Effect of sarcopenia on clinical outcomes following digestive carcinoma surgery: a meta-analysis. Supportive Care Cancer 27:2385–2394
Weerink L, Hoorn A, Leeuwen B, Bock G (2020) Low skeletal muscle mass and postoperative morbidity in surgical oncology: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 11:636–649
Su H, Ruan J, Chen T, Lin E, Shi L (2019) CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis. Cancer Imaging 19:82
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals Intern Med 151:264
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012
Goossen K, Tenckhoff S, Probst P, Grummich K, Mihaljevic A, Büchler M et al (2017) Optimal literature search for systematic reviews in surgery. Langenbeck's Arch Surg 403:119–129
Clavien P, Barkun J, de Oliveira M, Vauthey J, Dindo D, Schulick R et al (2009) The Clavien-Dindo classification of surgical complications. Ann Surg 250:187–196
Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M et al (2020) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses [accessed 15 Jun 2020] Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135
Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928–d5928
Wang S, Xie H, Gong Y, Kuang J, Yan L, Ruan G, Gao F, Gan J (2020) The value of L3 skeletal muscle index in evaluating preoperative nutritional risk and long-term prognosis in colorectal cancer patients. Sci Rep 10:8153
Richards S, Senadeera S, Frizelle F (2020) Sarcopenia, as assessed by psoas cross-sectional area, is predictive of adverse postoperative outcomes in patients undergoing colorectal cancer surgery. Dis Colon Rectum 63:807–815
Giani A, Famularo S, Riva L, Tamini N, Ippolito D, Nespoli L, Conconi P, Sironi S, Braga M, Gianotti L (2020) Association between specific presurgical anthropometric indexes and morbidity in patients undergoing rectal cancer resection. Nutrition 75-76:110779
Tokunaga R, Nakagawa S, Miyamoto Y, Ohuchi M, Izumi D, Kosumi K et al (2019) The clinical impact of preoperative body composition differs between male and female colorectal cancer patients. Color Dis 22:62–70
Pereira M, Pereira A, Silva P, Costa C, Martins S (2020) Sarcopenia as a risk factor of morbimortality in colorectal cancer surgery. Gastrointestinal Dis 2:107–117
Han JS, Ryu H, Park I, Kim K, Shin Y, Kim S et al (2020) Association of body composition with long-term survival in non-metastatic rectal cancer patients. Cancer Res Treat 52:563–572
Xie H, Gong Y, Kuang J, Yan L, Ruan G, Tang S, Gao F, Gan J (2020) Computed-tomography-determined sarcopenia is a useful imaging biomarker for predicting postoperative outcomes in elderly colorectal cancer patients. Cancer Res Treat 52(3):957–972
Shirdel M, Andersson F, Myte R, Axelsson J, Rutegård M, Blomqvist L, Riklund K, van Guelpen B, Palmqvist R, Gylling B (2020) Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease. Acta Oncol 59(7):799–808
Aro R, Mäkäräinen-Uhlbäck E, Ämmälä N, Rautio T, Ohtonen P, Saarnio J, Meriläinen S (2020) The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - a retrospective register study. Eur J Surg Oncol 46(9):1656–1662
Souwer E, Moos S, van Rooden C, Bijlsma A, Bastiaannet E, Steup W et al (2020) Physical performance has a strong association with poor surgical outcome in older patients with colorectal cancer. Eur J Surg Oncol 46:462–469
Olmez T, Karakose E, Keklikkiran Z, Ofluoglu C, Bas T, Uzun O et al (2020) Relationship between sarcopenia and surgical site infection in patients undergoing colorectal cancer surgical procedures. Surg Infect 21:451–456
Tankel J, Yellinek S, Vainberg E, David Y, Greenman D, Kinross J et al (2019) Sarcopenia defined by muscle quality rather than quantity predicts complications following laparoscopic right hemicolectomy. Int J Colorect Dis 35:85–94
Chen WS, Huang YS, Xu LB, Shi MM, Chen XD, Ye GQ, Wu TT, Zhu GB (2020) Effects of sarcopenia, hypoalbuminemia, and laparoscopic surgery on postoperative complications in elderly patients with colorectal cancer: a prospective study. Neoplasma 67(4):922–932
Ojima Y, Harano M, Sumitani D, Okajima M (2019) Impact of preoperative skeletal muscle mass and quality on the survival of elderly patients after curative resection of colorectal cancer. J Anus Rectum Colon 3:143–151
Hopkins J, Reif R, Bigam D, Baracos V, Eurich D, Sawyer M (2019) The impact of muscle and adipose tissue on long-term survival in patients with stage I to III colorectal cancer. Dis Colon Rectum 62:549–560
Hopkins J, Reif R, Bigam D, Baracos V, Eurich D, Sawyer M (2019) Change in skeletal muscle following resection of stage I–III colorectal cancer is predictive of poor survival: a cohort study. World J Surg 43:2518–2526
Dolan D, Knight K, Maguire S, Moug S (2019) The relationship between sarcopenia and survival at 1 year in patients having elective colorectal cancer surgery. Tech Coloproctol 23:877–885
Jochum S, Kistner M, Wood E, Hoscheit M, Nowak L, Poirier J et al (2019) Is sarcopenia a better predictor of complications than body mass index? Sarcopenia and surgical outcomes in patients with rectal cancer. Color Dis 21:1372–1378
Vashi P, Gorsuch K, Wan L, Hill D, Block C, Gupta D (2019) Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer. PLoS One 14:e0218761
Maurício S, Xiao J, Prado C, Gonzalez M, Correia M (2018) Different nutritional assessment tools as predictors of postoperative complications in patients undergoing colorectal cancer resection. Clin Nutr 37:1505–1511
Park S, Hwang I, Choi C, Kang H, Kim B, Park B et al (2018) Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy. Medicine 97:e13363
Kroenke C, Prado C, Meyerhardt J, Weltzien E, Xiao J, Cespedes Feliciano E et al (2018) Muscle radiodensity and mortality in patients with colorectal cancer. Cancer 124:3008–3015
Nakanishi R, Oki E, Sasaki S, Hirose K, Jogo T, Edahiro K et al (2017) Sarcopenia is an independent predictor of complications after colorectal cancer surgery. Surg Today 48:151–157
Deng C, Lin Y, Wu J, Cheung Y, Fan C, Yeh K et al (2018) Progressive sarcopenia in patients with colorectal cancer predicts survival. AJR Am J Roentgenol 210:526–532
Choi M, Oh S, Lee I, Oh S, Won D (2018) Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer. J Cachexia Sarcopenia Muscle 9:53–59
Mosk C, van Vugt J, de Jonge H, Witjes C, Buettner S, Ijzermans J et al (2018) Low skeletal muscle mass as a risk factor for postoperative delirium in elderly patients undergoing colorectal cancer surgery. Clin Interv Aging 13:2097–2106
Takeda Y, Akiyoshi T, Matsueda K, Fukuoka H, Ogura A, Miki H, Hiyoshi Y, Nagasaki T, Konishi T, Fujimoto Y, Fukunaga Y, Ueno M (2018) Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy. PLoS One 13:e0195406
Sueda T, Takahasi H, Nishimura J, Hata T, Matsuda C, Mizushima T et al (2018) Impact of low muscularity and myosteatosis on long-term outcome after curative colorectal cancer surgery. Dis Colon Rectum 61:364–374
Chen W, Chen X, Ma L, Zhang F, Lin J, Zhuang C et al (2018) Impact of visceral obesity and sarcopenia on short-term outcomes after colorectal cancer surgery. Dig Dis Sci 63:1620–1630
Van Der Kroft G, Bours D, Janssen-Heijnen D, van Berlo D, Konsten D (2018) Value of sarcopenia assessed by computed tomography for the prediction of postoperative morbidity following oncological colorectal resection: a comparison with the malnutrition screening tool. Clin Nutr ESPEN 24:114–119
Van Vugt J, Coebergh van den Braak R, Lalmahomed Z, Vrijland W, Dekker J, Zimmerman D et al (2018) Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer. Eur J Surg Oncol 44:1354–1360
Cespedes-Feliciano E, Kroenke C, Meyerhardt J, Prado C, Bradshaw P, Kwan M et al (2017) Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer. JAMA Oncol 3:e172319
Hanaoka M, Yasuno M, Ishiguro M, Yamauchi S, Kikuchi A, Tokura M, Ishikawa T, Nakatani E, Uetake H (2017) Morphologic change of the psoas muscle as a surrogate marker of sarcopenia and predictor of complications after colorectal cancer surgery. Int J Color Dis 32:847–856
Boer B, de Graaff F, Brusse-Keizer M, Bouman D, Slump C, Slee-Valentijn M et al (2016) Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancer. Int J Color Dis 31:1117–1124
Malietzis G, Currie A, Athanasiou T, Johns N, Anyamene N, Glynne-Jones R et al (2016) Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg 103:572–580
Pędziwiatr M, Pisarska M, Major P, Grochowska A, Matłok M, Przęczek K, Stefura T, Budzyński A, Kłęk S (2016) Laparoscopic colorectal cancer surgery combined with enhanced recovery after surgery protocol (ERAS) reduces the negative impact of sarcopenia on short-term outcomes. Eur J Surg Oncol 42:779–787
Ouchi A, Asano M, Aono K, Watanabe T, Oya S (2016) Laparoscopic colorectal resection in patients with sarcopenia: a retrospective case-control study. J Laparoendosc Adv Surg Tech A 26:366–370
Reisinger K, Derikx J, van Vugt J, Von Meyenfeldt M, Hulsewé K, Olde Damink S et al (2016) Sarcopenia is associated with an increased inflammatory response to surgery in colorectal cancer. Clin Nutr 35:924–927
Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, Kurashige J, Hiyoshi Y, Iwagami S, Yoshida N, Yoshida M, Watanabe M, Baba H (2015) Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 22:2663–2668
Huang D, Wang S, Zhuang C, Zheng B, Lu J, Chen F et al (2015) Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer. Color Dis 17:O256–O264
Jones K, Doleman B, Scott S, Lund J, Williams J (2014) Simple psoas cross-sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications. Color Dis 17:O20–O26
Jung H, Kim J, Kim J, Kim S, Yang H, Lee J et al (2015) Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer 23:687–694
Lieffers J, Bathe O, Fassbender K, Winget M, Baracos V (2012) Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 107:931–936
Fearon K, Strasser F, Anker S, Bosaeus I, Bruera E, Fainsinger R et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489–495
Prado C, Baracos V, McCargar L, Reiman T, Mourtzakis M, Tonkin K et al (2009) Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Rep 15:2920–2926
Camp R, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10:7252–7259
Martin L, Birdsell L, MacDonald N, Reiman T, Clandinin M, McCargar L et al (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539–1547
Joglekar S, Asghar A, Mott S, Johnson B, Button A, Clark E et al (2014) Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma. J Surg Oncol 111:771–775
Zhuang C, Huang D, Pang W, Zhou C, Wang S, Lou N et al (2016) Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer. Medicine 95:e3164
Okumura S, Kaido T, Hamaguchi Y, Fujimoto Y, Masui T, Mizumoto M, Hammad A, Mori A, Takaori K, Uemoto S (2015) Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 157:1088–1098
Kim E, Kim Y, Park I, Ahn H, Cho E, Jeong Y (2015) Prognostic significance of CT-determined sarcopenia in patients with small-cell lung cancer. J Thorac Oncol 10:1795–1799
Caan B, Meyerhardt J, Kroenke C, Alexeeff S, Xiao J, Weltzien E et al (2017) Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS study). Cancer Epidemiol Biomark Prev 26:1008–1015
Avrutin E, Moisey L, Zhang R, Khattab J, Todd E, Premji T et al (2018) Clinically practical approach for screening of low muscularity using electronic linear measures on computed tomography images in critically ill patients. JPEN J Parenter Enteral Nutr 42:885–891
Inokuchi S, Sugamiya H, Shibata M, Suzuki M, Ito J, Matsumara A (2001) Age related changes of the trunk muscle observed by CT image. Anthropol Sci 109:71–83
Peng P, van Vledder M, Tsai S, de Jong M, Makary M, Ng J et al (2011) Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB 13:439–446
Bijlsma A, Meskers C, Ling C, Narici M, Kurrle S, Cameron I et al (2012) Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. Age (Dordr) 35:871–881
Mourtzakis M, Prado C, Lieffers J, Reiman T, McCargar L, Baracos V (2008) A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33:997–1006
Han S, Kim K, Kim K, Na K, Chae D, Kim S et al (2010) Lean mass index: a better predictor of mortality than body mass index in elderly Asians. J Am Geriat Societ 58:312–317
Shachar S, Williams G, Muss H, Nishijima T (2016) Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer 57:58–67
Levolger S, van Vugt J, de Bruin R, IJzermans J (2015) Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies. Br J Surg 102:1448–1458
Williams G, Chen Y, Kenzik K, McDonald A, Shachar S, Klepin H et al (2020) Assessment of sarcopenia measures, survival, and disability in older adults before and after diagnosis with cancer. JAMA Netw Open 3:e204783
Kim T, Choi K (2013) Sarcopenia: definition, epidemiology, and pathophysiology. J Bone Metab 20:1–10
Peterson S, Mozer M (2017) Differentiating sarcopenia and cachexia among patients with cancer. Nutr Clin Pract 32:30–39
Van Vledder M, Levolger S, Ayez N, Verhoef C, Tran T, IJzermans J (2012) Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 99:550–557
Langlois F, Vu T, Kergoat M, Chassé K, Dupuis G, Bherer L (2012) The multiple dimensions of frailty: physical capacity, cognition, and quality of life. Int Psychogeriatr 24:1429–1436
Reisinger K, van Vugt J, Tegels J, Snijders C, Hulsewé K, Hoofwijk A et al (2015) Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg 261:345–352
Author information
Authors and Affiliations
Contributions
Mario Trejo-Avila: study conception design, data acquisition, data analysis, data interpretation, drafting the article, overall supervision, critical revision, and final approval.
Katya Bozada-Gutiérrez: data acquisition, data interpretation, drafting the article, overall supervision, critical revision, and final approval.
Carlos Valenzuela-Salazar: data acquisition and interpretation, drafting the article, overall supervision, critical revision, and final approval.
José Herrera-Esquivel: data acquisition and interpretation, drafting the article, overall supervision, critical revision, and final approval.
Mucio Moreno-Portillo: data acquisition and analysis, data interpretation, drafting the article, overall supervision, critical revision, and final approval.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All required data were retrieved from published articles. Hence, informed consent or ethical approval was not required.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Trejo-Avila, M., Bozada-Gutiérrez, K., Valenzuela-Salazar, C. et al. Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 36, 1077–1096 (2021). https://doi.org/10.1007/s00384-021-03839-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-021-03839-4